July 30 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI CEO Robert Koremans says in post-results conference call:
ITALY'S RECORDATI CEO: FROM WHAT WE HEAR THERE WILL BE 15% US TARIFF ON PHARMA PRODUCTS, RARE DISEASES ARE EXCLUDED
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.